- Rheumatoid arthritis—recent advances in pathogenesis and the anti-inflammatory effect of plant-derived COX inhibitors
Ubaid Bashir et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef - Piceatannol induces regulatory T cells and modulates the inflammatory response and adipogenesis
Ahmed Rakib et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Alkannin reverses lipopolysaccharides-induced inflammatory responses by suppressing mitogen-activated protein kinase and nuclear factor kappa-B signalling
Jingya Yang et al, 2022, Bioengineered CrossRef - Piceatannol protects against myocardial ischemia/reperfusion injury by inhibiting ferroptosis via Nrf-2 signaling-mediated iron metabolism
Mengmei Zhu et al, 2024, Biochemical and Biophysical Research Communications CrossRef - Predicting phase-I metabolism of piceatannol: an in silico study
Ravi Kumar Rajan et al, 2024, In Silico Pharmacology CrossRef - Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis
Yitong Tong et al, 2023, Frontiers in Pharmacology CrossRef - Panlongqi tablet suppresses adjuvant-induced rheumatoid arthritis by inhibiting the inflammatory reponse in vivo and in vitro
Xiaofeng Niu et al, 2023, Journal of Ethnopharmacology CrossRef